# Endolynx Inc. — Form D

Endolynx Inc. of JERSEY CITY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-06. The offering totals $30K, of which $30K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2023-03-06
- Form: D
- Accession: 0001967540-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $30K
- Amount sold: $30K
- Investors: 3
- Date of first sale: 2021-11-04
- Revenue range: Decline to Disclose
- SEC file number: 021-474945

## Issuer

- Name: Endolynx Inc.
- CIK: 0001967540
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 77 HUDSON STREET, JERSEY CITY, NJ, 07302
- Phone: (646) 504-4465

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Felek Jachimowicz | Director | Brookline, MA |
| Robert Jenkins | Director | Wakefield, MA |
| David Schaner | Director | Jersey City, NJ |
| Felek Jachimowicz | Executive Officer | Brookline, MA |
| Robert Jenkins | Executive Officer | Wakefield, MA |
| David Schaner | Executive Officer | Jersey City, NJ |

## More

- [CIK 1967540 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1967540&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001967540-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.